Speaking from Astra's offices in New York, Sir Pascal Soriot (pictured) said it was 'global', but it was 'very much rooted ...

AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 ...

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

The UK’s largest listed companies are turning their heads towards the glimmer of the Nasdaq after growing impatient at the lacklustre performance of the London Stock Exchange. Chief among them is ...

So Sir Pascal may seem an unlikely ally of Donald Trump, who as America’s president has slashed public spending on scientific ...

Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of ...

AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

Some home truths for London: One, it makes sense for AstraZeneca Plc to move its main listing to New York, and two, such a terrible symbolic blow for the UK would be hard to stop. The goal — if ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...